IOVANCE BIOTHERAPEUTICS, INC. Annual Depreciation in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2022.
  • Iovance Biotherapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $2.8M, a 55.6% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Depreciation for the twelve months ending March 31, 2023 was $10.3M, a 129% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Depreciation for 2022 was $9.3M, a 200% increase from 2021.
  • Iovance Biotherapeutics, Inc. annual Depreciation for 2021 was $3.1M, a 182% increase from 2020.
  • Iovance Biotherapeutics, Inc. annual Depreciation for 2020 was $1.1M, a 8.33% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.